In breast cancer, upregulation of RMRP partially resulted from its promoter mutation (Rheinbay et al., 2017) or Wnt/Hippo activation (Park and Jeong, 2015), but its biological function and the underlying mechanism in this cancer remain unclear. The gene discussed is RMRP; the disease is breast carcinoma.